AbbVie (ABBV): 97.7% of its 52-week range
On 2026-10-20, AbbVie (ABBV) closed at 289.08 USD, up 2.26% on the day. At the 2026-10-20 close, AbbVie (ABBV) traded at 97.7% of its 52-week range. At the 2026-10-20 close, AbbVie (ABBV) had an RSI(14) of 71.16, in the 92nd percentile of its history since 2013. Its 20-day return of +9.00% is in the 87th percentile of its history since 2013. RSI above 70 is conventionally termed overbought. The RSI(14) of AbbVie (ABBV) last entered the overbought zone today (2026-10-20) and the oversold zone 215 days ago (2026-03-19). It is trading above its 20-, 50- and 200-day moving averages. At the 2026-10-20 close, the 20/50/200-day moving averages of AbbVie (ABBV) were 272.03 / 264.01 / 234.52 USD, with price +6.27% / +9.50% / +23.27% against them. Ranked from highest to lowest, its moving averages are the 20-day, 50-day and 200-day. At the 2026-10-20 close, the 52-week range of AbbVie (ABBV) was 190.75–291.4 USD; it closed 0.80% below the high (0.4× its typical daily range) and 51.55% above the low (15.2× its typical daily range). The high was set 5 days ago (2026-10-15) and the low 174 days ago (2026-04-29). At the 2026-10-20 close, AbbVie (ABBV) was 0.80% below its all-time intraday high of 291.4 USD, set 5 days ago (2026-10-15). Its 20-day volatility is 1.320% daily, in the 44th percentile of its history since 2013. Its daily realised volatility is 1.729% over 5 days, 1.320% over 20 days, 1.388% over 60 days and 1.614% over 120 days. Annualised, these are 27.4%, 21.0%, 22.0% and 25.6% respectively. Its 14-day average true range (ATR) is 6.47 USD, 2.24% of price. It has returned +5.37% (93rd percentile since 2013) over 5 days, +8.40% (94th) over 10 days, +9.00% (87th) over 20 days, +12.52% (76th) over 60 days, +41.78% (97th) over 120 days and +25.92% (71st) over 252 days. Against the S&P 500, its weekly returns show a beta of -0.72 and a correlation of -0.31 over 52 weeks; over 26 weeks, a beta of -1.69 and a correlation of -0.55. Relative to the S&P 500, it has returned +6.56% (5-day), +9.76% (10-day), +9.67% (20-day), +8.48% (60-day) and +10.19% (252-day). Its weekly-return correlation with changes in the US 10-year TIPS real yield is -0.14 over 52 weeks and -0.12 over 26 weeks. Next earnings are scheduled for 2026-10-30.
Figures reflect the official regular-session close for 2026-10-20.
=== ABBVIE (ABBV) (USD) ===
price & change (as of 2026-10-20, prior 2026-10-19)
close 289.08
change +6.40 (+2.264%)
vs market S&P 500 +0.28% · Nasdaq 100 -0.10% (same day)
listing Exchange: NYSE, Currency: USD
range (as of 2026-10-20)
range 5.98
close pos 68.2% of range
moving averages (as of 2026-10-20)
20d MA 272.03 price above by +6.27%
50d MA 264.01 price above by +9.50%
200d MA 234.52 price above by +23.27%
200d MA slope +1.97% over 20 sessions (rising)
price > all MAs
stack: 20d > 50d > 200d
20d MA last crossed above 50d MA: 2026-05-27 (146d ago)
20d MA last crossed above 200d MA: 2026-06-22 (120d ago)
50d MA last crossed above 200d MA: 2026-07-09 (103d ago)
volatility (as of 2026-10-20)
20d stdev 1.320% daily ≈ 20.9% annualised (×√252) (44th pct of own history, since 2013 (3451 obs))
5d vol 1.729% daily ≈ 27.5% annualised (×√252) (75th pct of own history, since 2013 (3466 obs))
60d vol 1.388% daily ≈ 22.0% annualised (×√252) (39th pct of own history, since 2013 (3411 obs))
120d vol 1.614% daily ≈ 25.6% annualised (×√252) (57th pct of own history, since 2013 (3351 obs))
vs easing-2024 avg 0.82× (1.320% vs 1.602% era avg)
ATR (as of 2026-10-20)
ATR(14) 6.47
ATR% 2.24% (60th pct of own history, since 2013 (3457 obs))
range/ATR 92.4%
relative volume (as of 2026-10-20)
RVOL 1.06x (today vs prior 20-day average, excl. today)
pctile 67th pct of own history, since 2013 (3451 obs)
avg vol 63d 4,844,838 (≈3-month average daily share volume)
52-week range (as of 2026-10-20)
high 291.40 (-0.80% from high) [2026-10-15, 5d ago]
low 190.75 (+51.55% from low) [2026-04-29, 174d ago]
drawdown -0.80% from all-time intraday high, 5d ago (2026-10-15)
max drawdown (10-year, close-basis) -48.88% (2018-01-26 123.21 -> 2019-08-15 62.98, 566d peak-to-trough); recovered 2021-12-09 (847d after trough)
momentum (as of 2026-10-20)
RSI(14) 71.16 (92nd pct of own history, since 2013 (3457 obs))
last overbought 0d ago (2026-10-20)
last oversold 215d ago (2026-03-19)
MACD (as of 2026-10-20)
MACD(12,26,9) +6.65 (above signal) signal +5.10 hist +1.56
returns (as of 2026-10-20)
5d return +5.37% from 274.36 on 2026-10-13 (93rd pct of own history, since 2013 (3466 obs))
10d return +8.40% from 266.69 on 2026-10-06 (94th pct of own history, since 2013 (3461 obs))
20d return +9.00% from 265.21 on 2026-09-22 (87th pct of own history, since 2013 (3451 obs))
60d return +12.52% from 256.91 on 2026-07-27 (76th pct of own history, since 2013 (3411 obs))
120d return +41.78% from 203.89 on 2026-04-29 (97th pct of own history, since 2013 (3351 obs))
252d return +25.92% from 229.57 on 2025-10-17 (71st pct of own history, since 2013 (3219 obs))
YTD return +26.52% from 228.49 on 2025-12-31
volatility by rate-era
ZIRP (2009–2015) 1.73% (from 2013-01-02)
tightening (2015–2018) 1.75%
ZIRP (2019–2021) 1.77%
tightening (2022–2023) 1.33%
easing (2024– ) 1.60%
real-yield sensitivity (weekly returns vs weekly Δ in 10Y TIPS real yield, DFII10) (as of 2026-10-19)
vs real yield (Δ) -0.12 (26w)
vs real yield (Δ) -0.14 (52w)
S&P 500 market factor (weekly returns) (as of 2026-10-20)
vs S&P 500 beta -1.69 corr -0.55 (26w)
vs S&P 500 beta -0.72 corr -0.31 (52w)
vs S&P 500 +6.56% rel (5d return)
vs S&P 500 +9.76% rel (10d return)
vs S&P 500 +9.67% rel (20d return)
vs S&P 500 +8.48% rel (60d return)
vs S&P 500 +10.19% rel (252d return)
vs Nasdaq 100 beta -0.96 corr -0.61 (26w)
vs Nasdaq 100 beta -0.64 corr -0.44 (52w)
vs Nasdaq 100 +8.85% rel (5d return)
vs Nasdaq 100 +13.93% rel (10d return)
vs Nasdaq 100 +12.99% rel (20d return)
vs Nasdaq 100 +7.32% rel (60d return)
vs Nasdaq 100 +7.10% rel (252d return)
vs XLV (Health Care) beta +1.48 corr +0.82 (26w)
vs XLV (Health Care) beta +1.22 corr +0.72 (52w)
vs XLV -0.62% rel (5d return)
vs XLV +0.78% rel (10d return)
vs XLV +3.16% rel (20d return)
vs XLV +2.47% rel (60d return)
vs XLV +0.41% rel (252d return)
earnings horizon
next earnings 2026-10-30 (10 days)